A Double-blind, Placebo-controlled, Crossover Study, Followed by Open-label Study of KPS-0373 in Patients With SCD
A Double-blind, Placebo-controlled, Crossover Study, Followed by Open-label Study of KPS-0373 in Patients With SCD
To evaluate the efficacy and safety of KPS-0373 in patients with SCD.
Inclusion Criteria:
Exclusion Criteria:
Japan, Japan